Related Experiment Video
Updated: Jan 26, 2026
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Effects of Dexmedetomidine on Blood Glucose and Serum Potassium Levels in Children Undergoing General Anesthesia: A
Matthias Görges1,2, Andrew K Poznikoff1,3, Nicholas C West1
1From the Department of Anesthesiology, Pharmacology and Therapeutics, Uni versity of British Columbia, Vancouver, British Columbia, Canada.
Insights
Dexmedetomidine use in children caused temporary blood glucose increases and potassium decreases. Glucose elevation at 15 minutes showed a dose-dependent effect, warranting further pediatric anesthesia research.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Dexmedetomidine, a selective α2-adrenergic agonist, is increasingly used in pediatric anesthesia and intensive care.
- Potential adverse effects on glucose and potassium levels in children require rigorous evaluation due to their clinical significance.
- Understanding these effects is crucial for optimizing pediatric patient safety during anesthesia and critical care.
Purpose of the Study:
- To investigate the effects of three different doses of dexmedetomidine on blood glucose and serum potassium concentrations in children undergoing elective surgery.
- To establish dose-response relationships for these metabolic changes.
- To provide data for safer clinical application of dexmedetomidine in pediatric populations.
Main Methods:
- A randomized controlled trial involving 64 pediatric patients (ASA I-II) undergoing elective surgery.
- Patients received dexmedetomidine at doses of 0.25, 0.5, or 0.75 µg/kg, or placebo (0 µg/kg).
- Plasma glucose and serum potassium levels were measured at baseline, 15 minutes, and 30 minutes post-administration, analyzed using constrained longitudinal data analysis.
Main Results:
- Forty-nine children completed the study.
- Mean glucose levels increased at 15 and 30 minutes post-administration, with a significant dose-response relationship observed at 15 minutes.
- Serum potassium levels decreased at 15 and 30 minutes, although the effect was not dose-dependent.
Conclusions:
- Dexmedetomidine administration in children is associated with transient elevations in blood glucose and decreases in serum potassium.
- The observed increase in glucose at 15 minutes was dose-dependent, highlighting the need for careful dosing in pediatric patients.
- These findings suggest that while dexmedetomidine has metabolic effects, further research is warranted to fully understand their clinical implications in pediatric anesthesia.
Background:
Dexmedetomidine is a highly selective α2-adrenergic agonist, which is increasingly used in pediatric anesthesia and intensive care. Potential adverse effects that have not been rigorously evaluated in children include its effects on blood glucose and serum potassium concentrations, which are relevant due to the associations of derangements of both parameters with undesired outcomes. We investigated the effects of 3 different doses of dexmedetomidine on these outcomes in a randomized controlled trial in children undergoing elective surgery.
Methods:
Sixty-four American Society of Anesthesiologists I-II children were randomized to receive either dexmedetomidine 0.25 µg/kg, dexmedetomidine 0.5 µg/kg, dexmedetomidine 0.75 µg/kg, or 0 µg/kg (control), as a bolus administered over 60 seconds after induction of anesthesia. Changes in plasma glucose and serum potassium concentrations were measured in venous blood sampled before and at 15 and 30 minutes after study drug administration. Data were plotted within and between groups and analyzed using a constrained longitudinal data approach.
Results:
Forty-nine children completed the study. Mean glucose levels at 15 and 30 minutes were elevated with estimated changes from baseline of 0.37 mmol/L (95% CI, 0.29-0.45 mmol/L) and 0.05 mmol/L (95% CI, 0.00-0.10 mmol/L), respectively. At 15 minutes, there was a linear dose-response relationship (1.07 mmol/L/μg/kg [95% CI, 0.57-1.58 mmol/L/μg/kg]), but there was no appreciable effect of dexmedetomidine at 30 minutes (0.15 mmol/L/μg/kg [95% CI, -0.40 to 0.70 mmol/L/μg/kg]). Potassium levels were depressed relative to baseline, with a mean difference at 15 minutes of -0.20 mEq/L (95% CI, -0.28 to -0.12 mEq/L) and at 30 minutes of -0.12 mEq/L (95% CI, -0.15 to -0.08 mEq/L), but there was no appreciable effect of dexmedetomidine at either time.
Conclusions:
Small elevations in glucose and decreases in potassium were observed after induction of anesthesia in children. The elevation in glucose at 15 minutes depended on the dose of dexmedetomidine administered. These preliminary data warrant further investigation.
Related Concept Videos
01:02Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:16Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
01:55Secondary Active Transport
01:12Statistical Software for Data Analysis and Clinical Trials
01:28Survey Safety
01:26Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...